Outsourced Pharma Capacity Update Videos - Cell & Gene

  1. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

  2. Advancing Cell & Gene Therapies To Patients 4/24/2025

    Discover how we apply our expertise and know-how to efficiently advance your viral vector-based therapeutic through any phase, while enhancing quality and de-risking production.

  3. Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    See how Forge’s dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.

  4. Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    Here we introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development.

  5. Aldevron Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.

  6. Theragent Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Our Arcadia, CA facilities provide cell therapy development, testing, manufacturing, a proprietary digital trial platform, and preclinical research through our Discovery Center.

  7. Viralgen Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Advance your rAAV gene therapy from concept to commercial scale, leveraging our world-leading expertise and capacity to bring life-changing treatments to patients in need.

  8. Minaris Advanced Therapies Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    An update on our Philadelphia campus: comprehensive CGT services, from discovery to clinical production, with integrated bioanalytical testing to streamline timelines and reduce risks.

  9. ElevateBio Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Katie Jorgensen introduces ElevateBio BaseCamp's path to commercial readiness in cell therapy, highlighting key strategies for scaling from clinical to commercial manufacturing, with a focus on staffing, training, and preparation for 2025.

  10. Advanced Medicine Partners Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Gain insight into our unparalleled expertise as a leading CDMO in viral vectors, offering top-tier process development, analytical development, and manufacturing solutions.